28 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
to strengthen group-wide compliance systems. The Company has established its Code of Conduct, global policies (prohibition of bribery, handling of personal
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Code of Conduct, global policies (prohibition of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance-related internal rules, and implements training
6-K
EX-99.1
q4vvcyi5ygp
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
uc6 cpe979sclf
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
ai6lj2 ez
17 Dec 20
Current report (foreign)
6:01am
F-3ASR
EX-1.1
rsg pegbbws
24 Jun 20
Automatic shelf registration (foreign)
4:30pm
6-K
EX-99.1
ordbhtlvap2rf t16uq
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
hajxp4y
14 Nov 19
Prospectus supplement
6:10am
F-4/A
9klfprz
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
qc9l8l6l82
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
2cs6pk0al 888i
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
EX-10.7
toiscwyb
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.5
eej64 5ynt9k0ngqx
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.14
j1kwz9lkub61nh64
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am